连接ATP和全位,以实现与双价EGFR激酶抑制剂的超添加性结合
Florian Wittlinger1, Blessing C Ogboo2, Ekaterina Shevchenko1,3,4
1Department of Pharmaceutical and Medicinal Chemistry, Institute of Pharmaceutical Sciences, Eberhard Karls Universität Tübingen, Auf der Morgenstelle 8, 72076, Tübingen, Germany.
Communications chemistry
|February 20, 2024
概括
研究人员开发了强大的双价抑制剂,通过优化链接结构来向耐药EGFR突变. 这些新型分子同时结合ATP和全囊,显著增强抗癌活性对抗药物耐药的形式.
科学领域:
- 药用化学 医学化学
- 分子生物学分子生物学
- 结构生物学 结构生物学
背景情况:
- 双价分子提供了增强的目标结合,但由于复杂的架构,它们的设计具有挑战性.
- 开发有效的双价抑制剂需要仔细考虑链接器结构和几何.
研究的目的:
- 设计和合成表皮生长因子受体 (EGFR) 的新型双价抑制剂.
- 为了研究链接器修饰对抑制剂强度和结合耐药EGFR变体的影响.
主要方法:
- 使用了一种三位置换的伊米达ATP位子抑制剂和二二二松异位子抑制剂.
- 使用X射线晶体学可视化抑制剂-标相互作用并指导链接器重新设计.
- 合成并测试了针对EGFR突变的替代链接双价抑制剂.
主要成果:
- 水晶结构通过设计的链接器证实了ATP和全囊的成功跨越.
- 一个重新设计的链接器产生了一种与耐药EGFR (L858R/T790M和L858R/T790M/C797S) 相对显著增强功效 (~60 pM) 的化合物.
- 与单个母分子相比,观察到的强度是超添加的.
结论:
- 链接器工程对于优化双价抑制剂的活性至关重要.
- 这项研究提供了关于设计针对耐药EGFR的强有力的双价剂的链接器的见解.
- 优化的双价抑制剂对具有挑战性的耐药性癌症突变表现出卓越的疗效.
相关概念视频
Ligand Binding and Linkage
4.8K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.8K
Receptor Tyrosine Kinases
12.9K
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
12.9K
Transducer Mechanism: Enzyme-Linked Receptors
2.5K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.5K
Allosteric Regulation
58.0K
Allosteric regulation of enzymes occurs when the binding of an effector molecule to a site that is different from the active site causes a change in the enzymatic activity. This alternate site is called an allosteric site, and an enzyme can contain more than one of these sites. Allosteric regulation can either be positive or negative, resulting in an increase or decrease in enzyme activity. Most enzymes that display allosteric regulation are metabolic enzymes involved in the degradation or...
58.0K
Allosteric Proteins-ATCase
5.7K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
5.7K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K


